Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for TEVETEN

Brand name

TEVETEN

Company Name

BGP PHARMA ULC

Drug Identification Number

02240432

Ingredients & Strength

EPROSARTAN (400 MG)

ATC Code

C09CA
C09CA

ATC Descriptor

ANGIOTENSIN II ANTAGONISTS, PLAIN
ANGIOTENSIN II ANTAGONISTS, PLAIN

Status

CANCELLED POST MARKET

Shortage reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports
TEVETEN	2x14	Resolved	2017-11-20	2018-01-06	29736
TEVETEN	2 x 14	Resolved	2019-05-08	2019-10-23	83432
TEVETEN	14x2	Resolved	2020-01-13	2020-07-23	103139
TEVETEN	14x2	Avoided shortage	2020-09-22	2020-11-10	124713
TEVETEN	14x2	Resolved	2020-12-01	2021-02-04	129203
TEVETEN	2x14	Resolved	2022-10-05	2024-12-10	171165

1

Showing 1 to 6 of 6

Discontinuation reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0

Reports for TEVETEN

Brand name TEVETEN

Brand name

TEVETEN